Gen-AI Designed Enzymes for Pharmaceutical Innovation
Company is active
Event Year: 2023
Company is active
Event Year: 2023
Pando Bioscience is pioneering a new era in enzyme engineering for the pharmaceutical sector through the application of artificial intelligence and synthetic biology. Their innovative, AI-powered platform significantly accelerates and enhances enzyme screening processes. By leveraging ultra-high-throughput screening, Pando Bioscience achieves a remarkable 1000-fold increase in screening capacity, completing the process 75% faster and at 80% of the cost compared to conventional techniques. This advanced screening capability fuels their generative AI, enabling the efficient optimization of enzymes across a spectrum of properties. The result is the creation of high-performance, custom-designed enzymes that lower operational expenses and improve overall efficiency in pharmaceutical development and manufacturing.
Pando Bioscience is pioneering a new era in enzyme engineering for the pharmaceutical sector through the application of artificial intelligence and synthetic biology. Their innovative, AI-powered platform significantly accelerates and enhances enzyme screening processes. By leveraging ultra-high-throughput screening, Pando Bioscience achieves a remarkable 1000-fold increase in screening capacity, completing the process 75% faster and at 80% of the cost compared to conventional techniques. This advanced screening capability fuels their generative AI, enabling the efficient optimization of enzymes across a spectrum of properties. The result is the creation of high-performance, custom-designed enzymes that lower operational expenses and improve overall efficiency in pharmaceutical development and manufacturing.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2023
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2023
Healthcare
Healthcare
Healthcare -> Industrial Bio
Healthcare -> Industrial Bio
Team size: 5
Hiring: No
Team size: 5
Hiring: No